Loading…
Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease
In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12...
Saved in:
Published in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2000-08, Vol.36 (2), p.220-225 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3 |
container_end_page | 225 |
container_issue | 2 |
container_start_page | 220 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 36 |
creator | Schwartzkopff, Bodo Brehm, Michael Mundhenke, Markus Strauer, Bodo E |
description | In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease. |
doi_str_mv | 10.1161/01.HYP.36.2.220 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71761000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>58594090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</originalsourceid><addsrcrecordid>eNpdkVFr2zAQgMVYWdNsz3sbYoy-2dXJsiQ_hqxdBoWV0bENBuJsn4k7x0ole6X_fioJbPTh0MF9d9x9YuwtiBxAw4WAfPPzJi90LnMpxQu2gFKqTJW6eMkWAiqVVQA_TtlZjHdCgFLKvGKnICplhYUF-_WV9tgH7ju-9sGPGB75KkwUej9Q5Ksupfw2EE47Gif-vZ-2_CZVx9bvQz_wfuSbxz2ljjH2f4hvCMPEP_aRMNJrdtLhEOnN8V2yb1eXt-tNdv3l0-f16jprlNEyM1VrFFa1NUXZiq5DrI0ttawNoaxRVlo0afOqNFYDlpUCU4JqOyg7UyBgsWTnh7n74O9nipPb9bGhYcCR_BydAaNBCJHA98_AOz-HMe3mpCilBWNVgi4OUBN8jIE6ly7dJTEOhHuy7gS4ZN0V2kmXrKeOd8exc72j9j_-oDkBH44AxgaHLuDY9PEfp4wt0pctmTpgD35I3uPvYX6g4LaEw7R16QChpLaZfMpsiiwFyOIvSMeYdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205281784</pqid></control><display><type>article</type><title>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</title><source>EZB Electronic Journals Library</source><creator>Schwartzkopff, Bodo ; Brehm, Michael ; Mundhenke, Markus ; Strauer, Bodo E</creator><creatorcontrib>Schwartzkopff, Bodo ; Brehm, Michael ; Mundhenke, Markus ; Strauer, Bodo E</creatorcontrib><description>In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.36.2.220</identifier><identifier>PMID: 10948081</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive agents ; Arterioles - drug effects ; Arterioles - pathology ; Arterioles - physiopathology ; Biological and medical sciences ; Blood Pressure - drug effects ; Cardiovascular system ; Coronary Circulation - drug effects ; Coronary Vessels - drug effects ; Coronary Vessels - pathology ; Coronary Vessels - physiopathology ; Dipyridamole - pharmacology ; Female ; Heart Diseases - drug therapy ; Heart Diseases - physiopathology ; Heart Ventricles - drug effects ; Heart Ventricles - pathology ; Hemodynamics - drug effects ; Humans ; Hypertension - drug therapy ; Hypertension - physiopathology ; Male ; Medical sciences ; Middle Aged ; Myocardium - pathology ; Perindopril - therapeutic use ; Pharmacology. Drug treatments ; Prospective Studies ; Treatment Outcome ; Vascular Resistance - drug effects ; Vasodilator Agents - pharmacology</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2000-08, Vol.36 (2), p.220-225</ispartof><rights>2000 American Heart Association, Inc.</rights><rights>2000 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Aug 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</citedby><cites>FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1478356$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10948081$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwartzkopff, Bodo</creatorcontrib><creatorcontrib>Brehm, Michael</creatorcontrib><creatorcontrib>Mundhenke, Markus</creatorcontrib><creatorcontrib>Strauer, Bodo E</creatorcontrib><title>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease.</description><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive agents</subject><subject>Arterioles - drug effects</subject><subject>Arterioles - pathology</subject><subject>Arterioles - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiovascular system</subject><subject>Coronary Circulation - drug effects</subject><subject>Coronary Vessels - drug effects</subject><subject>Coronary Vessels - pathology</subject><subject>Coronary Vessels - physiopathology</subject><subject>Dipyridamole - pharmacology</subject><subject>Female</subject><subject>Heart Diseases - drug therapy</subject><subject>Heart Diseases - physiopathology</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - pathology</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardium - pathology</subject><subject>Perindopril - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Treatment Outcome</subject><subject>Vascular Resistance - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpdkVFr2zAQgMVYWdNsz3sbYoy-2dXJsiQ_hqxdBoWV0bENBuJsn4k7x0ole6X_fioJbPTh0MF9d9x9YuwtiBxAw4WAfPPzJi90LnMpxQu2gFKqTJW6eMkWAiqVVQA_TtlZjHdCgFLKvGKnICplhYUF-_WV9tgH7ju-9sGPGB75KkwUej9Q5Ksupfw2EE47Gif-vZ-2_CZVx9bvQz_wfuSbxz2ljjH2f4hvCMPEP_aRMNJrdtLhEOnN8V2yb1eXt-tNdv3l0-f16jprlNEyM1VrFFa1NUXZiq5DrI0ttawNoaxRVlo0afOqNFYDlpUCU4JqOyg7UyBgsWTnh7n74O9nipPb9bGhYcCR_BydAaNBCJHA98_AOz-HMe3mpCilBWNVgi4OUBN8jIE6ly7dJTEOhHuy7gS4ZN0V2kmXrKeOd8exc72j9j_-oDkBH44AxgaHLuDY9PEfp4wt0pctmTpgD35I3uPvYX6g4LaEw7R16QChpLaZfMpsiiwFyOIvSMeYdA</recordid><startdate>200008</startdate><enddate>200008</enddate><creator>Schwartzkopff, Bodo</creator><creator>Brehm, Michael</creator><creator>Mundhenke, Markus</creator><creator>Strauer, Bodo E</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>200008</creationdate><title>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</title><author>Schwartzkopff, Bodo ; Brehm, Michael ; Mundhenke, Markus ; Strauer, Bodo E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive agents</topic><topic>Arterioles - drug effects</topic><topic>Arterioles - pathology</topic><topic>Arterioles - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiovascular system</topic><topic>Coronary Circulation - drug effects</topic><topic>Coronary Vessels - drug effects</topic><topic>Coronary Vessels - pathology</topic><topic>Coronary Vessels - physiopathology</topic><topic>Dipyridamole - pharmacology</topic><topic>Female</topic><topic>Heart Diseases - drug therapy</topic><topic>Heart Diseases - physiopathology</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - pathology</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardium - pathology</topic><topic>Perindopril - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Treatment Outcome</topic><topic>Vascular Resistance - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartzkopff, Bodo</creatorcontrib><creatorcontrib>Brehm, Michael</creatorcontrib><creatorcontrib>Mundhenke, Markus</creatorcontrib><creatorcontrib>Strauer, Bodo E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartzkopff, Bodo</au><au>Brehm, Michael</au><au>Mundhenke, Markus</au><au>Strauer, Bodo E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2000-08</date><risdate>2000</risdate><volume>36</volume><issue>2</issue><spage>220</spage><epage>225</epage><pages>220-225</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>10948081</pmid><doi>10.1161/01.HYP.36.2.220</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2000-08, Vol.36 (2), p.220-225 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_miscellaneous_71761000 |
source | EZB Electronic Journals Library |
subjects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive agents Arterioles - drug effects Arterioles - pathology Arterioles - physiopathology Biological and medical sciences Blood Pressure - drug effects Cardiovascular system Coronary Circulation - drug effects Coronary Vessels - drug effects Coronary Vessels - pathology Coronary Vessels - physiopathology Dipyridamole - pharmacology Female Heart Diseases - drug therapy Heart Diseases - physiopathology Heart Ventricles - drug effects Heart Ventricles - pathology Hemodynamics - drug effects Humans Hypertension - drug therapy Hypertension - physiopathology Male Medical sciences Middle Aged Myocardium - pathology Perindopril - therapeutic use Pharmacology. Drug treatments Prospective Studies Treatment Outcome Vascular Resistance - drug effects Vasodilator Agents - pharmacology |
title | Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Repair%20of%20Coronary%20Arterioles%20After%20Treatment%20With%20Perindopril%20in%20Hypertensive%20Heart%20Disease&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Schwartzkopff,%20Bodo&rft.date=2000-08&rft.volume=36&rft.issue=2&rft.spage=220&rft.epage=225&rft.pages=220-225&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.36.2.220&rft_dat=%3Cproquest_cross%3E58594090%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205281784&rft_id=info:pmid/10948081&rfr_iscdi=true |